Omega Healthcare Investors Inc. (OHI)
Omega Healthcare Investors (OHI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Omega Healthcare Investors (OHI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Omega Healthcare Investors Q2 Earnings Call Highlights
Omega Healthcare Investors NYSE: OHI reported second-quarter 2026 results marked by higher revenue, a large gain from asset sales, improved portfolio coverage and an increased full-year Adjusted FFO outlook, while management outlined plans for greater investment activity in the second half of the year.
Omega Healthcare Investors, Inc. (OHI) Q2 2026 Earnings Call Transcript
Omega Healthcare Investors, Inc. (OHI) Q2 2026 Earnings Call Transcript
Omega Healthcare Investors: The Silver Tsunami Now Looks Priced In (Rating Downgrade)
Omega Healthcare Investors is now rated Hold as its valuation aligns with fair value, reflecting a balanced risk-reward profile. OHI's SHOP/RIDEA operational pivot positions it to capture upside from demographic tailwinds but introduces greater operational risk and volatility. Q2 results showed AFFO up 12.55% YoY, a dividend increase after years of pause, and upgraded 2026 AFFO guidance to $3.22–$3.26 per share.
Omega Healthcare Investors (OHI) Q2 FFO and Revenues Beat Estimates
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.77 per share a year ago.
Omega Healthcare Investors (OHI) Upgraded to Buy: Here's What You Should Know
Omega Healthcare Investors (OHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Omega Healthcare: Still A Great Company, But No Longer The Bargain It Was
Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI's dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential.
Omega Healthcare Investors: High Yield, Improving Fundamentals, Attractive Price
Omega Healthcare Investors offers a compelling high-yield opportunity after a recent price pullback, now yielding over 6%. OHI's fundamentals are robust, with FAD per share up 9.5% YoY, improved dividend coverage at 86%, and tenant rent coverage at a decade high. Strategic expansion into RIDEA structures and value-added acquisitions positions OHI for potentially strong total returns.
Omega Healthcare Investors, Inc. (OHI) Q1 2026 Earnings Call Transcript
Omega Healthcare Investors, Inc. (OHI) Q1 2026 Earnings Call Transcript
Omega Healthcare Investors: A High-Yield Play On The Silver Tsunami With RIDEA Upside
Omega Healthcare Investors is rated Buy, with strong long-term potential and a valuation reflecting elevated risk. OHI delivered a solid Q1, raised 2026 AFFO guidance to $3.19–$3.25 per share, and advanced its SHOP/RIDEA operational pivot. Risks include macro headwinds from the Iran conflict, higher rates, tenant pressures, and increased operational exposure from the SHOP model.
Omega Healthcare Investors (OHI) Q1 FFO and Revenues Beat Estimates
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.82 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.75 per share a year ago.
Advisors Capital Management LLC Boosts Stock Position in Omega Healthcare Investors, Inc. $OHI
Advisors Capital Management LLC boosted its holdings in Omega Healthcare Investors, Inc. (NYSE: OHI) by 2.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 936,433 shares of the real estate investment trust's stock after purchasing an additional 18,342 shares
